Varicellon

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Varicella zoster immunoglobulin preparation for i.m. application.

IndicationThis section has been translated automatically.

Prophylaxis of varicella in at-risk patients, pregnant women without a varicella history and newborns whose mothers have been affected by varicella or zoster for up to 96 hours prepartum or up to 48 hours post partum. Also for the treatment of zoster patients under immunosuppressive treatment.

Dosage and method of useThis section has been translated automatically.

At least 0,2 ml/kg bw i.m.

Undesirable effectsThis section has been translated automatically.

Hypersensitivity, temperature rise.

ContraindicationThis section has been translated automatically.

Hypersensitivity to homologous immunoglobulins.

Authors

Last updated on: 29.10.2020